EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses small, targeted amounts of steam to kill cancer cells is a safe and effective ...

Sir Chris Hoy hailed the fundraising as a “huge step forward” in the fight to make change. "The huge sum Paddy Power are ...

Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Penile Cancer.

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Prostate cancer is one of the most common cancers in men worldwide, primarily affecting older men. The prostate is a small, walnut-shaped gland located just below the bladder and in front of the ...

Telix Pharmaceuticals Limited  and the Brussels-based Oncidium foundation today announce that results for the NOBLE Registry of TLX599-CDx (99mTc-iPSMA) have been published in the European Journal of ...

The 5-year survival rates for prostate cancer at various stages are as follows: Localized and regional: around 99% for both Black and white men Advanced disease: around 30% in Black and white men ...

Gemini Advanced subscribers are getting access to a new “Deep Research” capability. It is the “first feature in Gemini” to bring Google’s vision of agents that can perform complex ...